Author:
Masud R.,Khan A. U. H.,Baqai H. Z.,Iqbal A.
Reference51 articles.
1. Guven, M., Ismailoglu, Z., Batar, B., et al., The effect of genetic polymorphisms of TLR2 and TLR4 in Turkish patients with coronary artery disease, Gene, 2015, vol. 558, no. 1, pp. 99–102.
2. Masud, R. and Qureshi, I.Z., Tetra primer ARMS-PCR relates folate/homocysteine pathway genes and ACE gene polymorphism with coronary artery disease, Mol. Cell. Biochem., 2011, vol. 355, nos. 1—2, pp. 289–297.
3. Shabana, N.A., Ashiq, S., Ijaz, A., et al., Genetic risk score (GRS) constructed from polymorphisms in the PON1, IL-6, ITGB3, and ALDH2 genes is associated with the risk of coronary artery disease in Pakistani subjects, Lipids Health Dis., 2018, vol. 17, no. 1, p. 224.
4. Khan, M.A., Hashim, M.J., Mustafa, H., et al., Global epidemiology of ischemic heart disease: results from the global burden of disease study, Cureus, 2020, vol. 12, no. 7. e9349
5. Li, Y., Yan, H., Guo, J., et al., Down-regulated RGS5 by genetic variants impairs endothelial cell function and contributes to coronary artery disease, Cardiovasc. Res., 2019.